Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug 26;58(2):2101076.
doi: 10.1183/13993003.01076-2021. Print 2021 Aug.

Biologics may have a beneficial effect in asthma patients with COVID-19

Affiliations
Comment

Biologics may have a beneficial effect in asthma patients with COVID-19

José L Izquierdo et al. Eur Respir J. .

Abstract

Biologics may have a beneficial effect in asthma patients with COVID-19 https://bit.ly/3hkor8X

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: J.L. Izquierdo reports personal fees from AstraZeneca, Bayer, Boehringer Ingelheim, Chiesi, GSK, Grifols, Menarini, Novartis, Orion, Pfizer, Sandoz and Teva. Conflict of interest: J.B. Soriano has nothing to disclose.

Comment on

  • The impact of COVID-19 on patients with asthma.
    Izquierdo JL, Almonacid C, González Y, Del Rio-Bermudez C, Ancochea J, Cárdenas R, Lumbreras S, Soriano JB. Izquierdo JL, et al. Eur Respir J. 2021 Mar 4;57(3):2003142. doi: 10.1183/13993003.03142-2020. Print 2021 Mar. Eur Respir J. 2021. PMID: 33154029 Free PMC article.

References

    1. Izquierdo JL, Almonacid C, González Y, et al. . The impact of COVID-19 on patients with asthma. Eur Respir J 2021; 57: 2003142. doi:10.1183/13993003.03142-2020 - DOI - PMC - PubMed
    1. Pala D, Pistis M. Anti-IL5 drugs in COVID-19 patients: role of eosinophils in SARS-CoV-2-induced immunopathology. Front Pharmacol 2021; 12: 622554. doi:10.3389/fphar.2021.622554 - DOI - PMC - PubMed